drug
Quillivant XR
Marketedupdated 2mo agoby Tris Pharma Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 8- tagApproval430 co-mentions · 201 sources
- drugMETADATE CD406 co-mentions · 206 sources
- drugMETADATE ER262 co-mentions · 206 sources
- drugRITALIN LA245 co-mentions · 206 sources
- drugMethylin233 co-mentions · 206 sources
- drugMETHYLIN ER233 co-mentions · 206 sources
- drugmethylphenidate hydrochloride ER225 co-mentions · 206 sources
- drugRelexxii223 co-mentions · 206 sources
all catalysts(0)
nothing on the calendar yet
Trials studying Quillivant XR
- phase3Efficacy, Safety & Pharmacokinetic (PK) Study of HLD200 in Children Aged 4-5 Years With ADHD
- phase1Dexmethylphenidate Hydrochloride Tablets Under Fasting Conditions
- phase1Dexmethylphenidate Hydrochloride Tablets Under Non-Fasting Conditions
- phase4A 14 Week, Randomized, Placebo-Controlled Cross-Over Study of Methylphenidate Hydrochloride Controlled Release Capsules in Adult ADHD With and Without Anxiety Disorder Comorbidity
Patent cliff
source: FDA Orange Bookfirst barrier falls
Mar 29, 2029
~2.7 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (7)
- Feb 15, 2031formulationUS 82879034.6y
- Feb 15, 2031formulationUS 84657654.6y
- Feb 15, 2031formulationUS 85630334.6y
- Feb 15, 2031formulationUS 87783904.6y
- Feb 15, 2031formulationUS 89566494.6y
- Feb 15, 2031formulationUS 90400834.6y
- Mar 29, 2029formulationUS 80626672.7y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 49m ago
Found something off?
comments(0)
5-min edit window · permanent after that